Recruitment strategies for a multisite telehealth trial for rural cancer survivors with ostomies.

Publication date: May 22, 2026

Ostomies, the surgical exteriorization of bowel for urine or stool, are part of the treatment of some cancers. We completed a randomized clinical trial testing a curriculum to help cancer survivors with ostomies in rural areas delivered by telehealth. The aim of this report is to describe modifications necessary to complete accrual in this population of cancer survivors. Rural cancer survivors with ostomies at least 6 weeks postoperatively were randomized to group educational sessions via telehealth versus usual care. The curriculum was delivered once per week over 5 weeks; primary patient reported endpoints were at 6 months. Initial sites were University of North Carolina, City of Hope National Medical Center, and Geisinger Medical Center. Rurality was initially defined utilizing the rural-urban commuting area (RUCA) codes as 4+ (excluding RUCA 1, 2, 3). This study was open from August 16, 2019, to February 9, 2024. Accrual was more challenging after the COVID pandemic began in March 2020. Multiple modifications were needed to address trial recruitment challenges. Our amendments included adding six sites across the USA, expanding inclusion criteria to include RUCA 3 and then RUCA 2, and adding distance from ostomy nursing care, first to those living greater than 45 miles, and subsequently more than 25 miles. Accrual to cancer survivorship trials may be difficult, and unpredictable circumstances such as the worldwide pandemic may require research teams to be flexible and creative with recruitment strategies. Modifications may be necessary to ensure accrual yet maintain study integrity. This study was registered on Clinicaltrials. gov (NCT # 03913715) on 5/29/2019.

Open Access PDF

Concepts Keywords
Cancers Cancer Survivors
Clinicaltrials Cancer survivors
February COVID-19
Rurality Female
Humans
Male
Middle Aged
Neoplasms
Ostomy
Ostomy
Patient Selection
Rural
Rural Population
Telemedicine
Telemedicine

Semantics

Type Source Name
disease MESH cancer
disease MESH included
disease MESH urologic cancers
disease MESH face
drug DRUGBANK Spinosad
disease MESH COVID 19 pandemic
drug DRUGBANK Methionine
drug DRUGBANK Ranitidine
disease MESH Hos
drug DRUGBANK Etoperidone
disease MESH tals
pathway REACTOME Translation
drug DRUGBANK Trestolone
drug DRUGBANK Methylphenidate
pathway REACTOME Reproduction
disease MESH rectal cancer
disease MESH carcinoma
disease MESH bjs
disease MESH HHS
disease MESH ers
drug DRUGBANK Guanosine
drug DRUGBANK Serine
disease MESH emergency

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *